Oral Cancer Research Initiative

Oral cancer is one of the most pernicious epithelial malignancies in the world, whose incidence is on the rise. Despite progress in diagnosis and treatment of oral cancer, the 5-year survival rates over the past twenty years have remained at about 50%. Oral cancer disproportionately affects underserved minorities in the US and in the developing countries.

The Oral Cancer Research Initiative (OCRI) is a focused multidisciplinary collaborative that brings together basic scientists, clinicians, public health researchers, engineers, chemists and computational biologists to work on diverse issues related to oral cancer.

Our mission: to elucidate the mechanisms of oral cancer development and progression and to expedite translation of research findings toward diagnosis, prevention, treatment and cure of oral cancer. Our multidisciplinary effort will align research on oral cancer with societal needs. For more information regarding the Oral Cancer Research Initiative please contact ocri@bu.edu

Rhoda M. Alani, M.D.
Herbert Mescon Professor & Chair, Department of Dermatology, School of Medicine

David M. Center, M.D.
Chief, Pulmonary, Allergy & Critical Care Medicine
Gordon & Ruth Snider Professor of Pulmonary Medicine
Professor of Medicine & Biochemistry
Associate Provost for Translational Research
Director, Boston University Medical Campus Translational Research Institute

David L. Coleman, M.D.
Wade Professor & Chair, Department of Medicine

Ronald B. Corley, Ph.D.
Professor & Chair of Microbiology
Associate Provost for Research, Boston University Medical Campus

Jeffrey W. Hutter, D.M.D., M.Ed.
Dean, Henry M. Goldman School of Dental Medicine
Spencer N. Frankl Professor in Dental Medicine

Katya Ravid, D.Sc., Ph.D.
Professor of Medicine & Biochemistry
Director, Evans Center for Interdisciplinary Biomedical Research

M. Selim Ünlü, M.S.E.E., Ph.D.
Professor of Electrical and Computer Engineering
Associate Director, Boston University Center for Nanoscience and Nanobiotechnology

Roberta F. White, Ph.D.
Associate Dean for Research
Professor of Environmental Health, School of Public Health

Thomas J. Glynn, Ph.D.
Director, Cancer Science & Trends
Director, International Cancer Control, American Cancer Society

Jennifer Grandis, M.D.
Director, Head & Neck SPORE
Professor of Otolaryngology, University of Pittsburgh

Bruce Johnson, M.D.
Chief Clinical Research Officer, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

Scott M. Lippman, M.D.
Director, Head & Neck SPORE
Chair, Thoracic/Head & Neck Medical Oncology
University of Texas MD Anderson Cancer Center

Poul Erik Petersen, D.D.S., D.O.Sc., M.Sc.
Chief, Oral Health Programme, World Health Organization

Marshall Posner, M.D.
Director, Head & Neck Medical Oncology
Director, Office of Cancer Clinical Trials
The Tisch Cancer Institute
Mount Sinai School of Medicine

Jatin P. Shah, M.D., F.A.C.S.
Chairman of the Council of the International Academy of Oral Oncology
Professor of Surgery, Cornell University
Chief of Head & Neck Surgery Service,
Memorial Sloan-Kettering Cancer Center

Dong M. Shin, M.D., F.A.C.P.
Director, Head & Neck SPORE
Professor of Hematology, Oncology & Otolaryngology
Director, Clinical & Translational Cancer Prevention Program
Winship Cancer Institute
Emory University School of Medicine

Gregory T. Wolf, M.D.
Director, Head & Neck SPORE
Professor of Otolaryngology, University of Michigan


OCRI News

  • OCRI Explores Biorepository Collaboration with Erie County Medical Center

    February 26, 2016

    On February 1, Dr. Jennifer Frustino visited Boston University and met with OCRI researchers to explore biospecimen repository collaboration opportunities. Dr. Frustino is the Director of Oral Cancer Screening and Diagnostics in the Division of Oral Oncology and Maxillofacial Prosthetics at Erie County Medical Center in Buffalo, NY. Previously, she... [ More ]

  • Paper Published by OCRI Members Selected as AACR Editors’ Pick

    February 26, 2016

    The American Association for Cancer Research (AACR) selected an article written by members of the Boston University Medical Campus (BUMC) community as one of the AACR Journals Editors’ Picks for 2015. The article, “A YAP/TAZ-Regulated Molecular Signature is Associated with Oral Squamous Cell Carcinoma” was published in Molecular Cancer Research... [ More ]

  • Etiology and Pathogenesis of Oral Cancer ARC Funded For a Third Year

    February 26, 2016

    The Etiology and Pathogenesis of Oral Cancer (EPOC) Affinity Research Collaborative (ARC) was recently successful in its application for a third year of funding. The EPOC ARC is co-funded by the Evans Center for Interdisciplinary Biomedical Research and the Boston University Henry M. Goldman School of Dental Medicine (GSDM). The... [ More ]

News Archive


Also See…